We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SILC:NASDAQSilicom Ltd Analysis

Data as of 2026-06-22 - not real-time

$46.95

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical outlook: The short‑term moving average sits above the longer‑term moving average, indicating bullish momentum, while the RSI sits in a neutral zone. Momentum indicators show a bearish MACD divergence and price is trading near the upper end of its recent range, with a clear support level below and resistance above. Volume has been stable, but recent price swings have been very high and the stock’s beta is well above the market, suggesting heightened price sensitivity.
Fundamental outlook: Revenue is expanding at a solid pace, yet the company continues to generate negative margins and lacks operating cash flow, leaving it reliant on cash reserves. Leverage is elevated relative to equity, and earnings per share remain in the red, resulting in a negative price‑to‑earnings metric. No dividend is paid, and valuation multiples appear stretched given the profit profile. The product portfolio spans networking and edge solutions, which could benefit from broader industry trends, but execution risk remains high.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish short‑term moving average crossover
  • Neutral RSI suggesting no immediate overbought pressure
  • Bearish MACD divergence and high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth offset by negative margins
  • Elevated leverage and lack of cash flow
  • Industry tailwinds for networking and edge solutions

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained earnings deficits and negative earnings per share
  • High beta and volatility increasing downside risk
  • Absence of dividend and stretched valuation relative to fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth32.80%
Profit Margin-16.57%
P/E Ratio-102.1
ROE-9.17%
ROA-4.80%
Debt/Equity5.69
P/B Ratio2.3
Industry P/E38.1

Technical Analysis

TrendBullish
RSI56.7
Support$37.12
Resistance$49.76
MA 20$44.27
MA 50$39.01
MA 200$22.70
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.81
Volatility103.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.